J&J Asks Other Companies to Join Investigation of Blood Clotting After COVID-19 Vaccination
Recently, federal healthcare agencies have advised Johnson & Johnson to cease administering their COVID-19 vaccine temporarily. According to Reuters, this advice was given after six women under fifty developed blood clotting following the shot. Business Insider reports that the women were between the ages of eighteen and forty-eight and now suffer from a blood clot in the brain called central venous sinus thrombosis (CVST). Overall, 6.8 million Americans have had the J&J vaccine.
Read More